When a vaccine to fight COVID-19 has been approved by the FDA for distribution, it鈥檚 unlikely that at first there will be enough doses for everyone. Consequently, the United States will need an equitable and effective plan for who gets those first doses, how they get them and who鈥檚 next. Just as important, that plan 鈥� like the vaccine itself 鈥斅爃as to be trusted and accepted by the general public. To accomplish this complicated and potentially fraught task, the CDC聽Advisory…
